A 55-year-old patient is brought to the emergency department with a myocardial infarction. The doctor immediately administers a bioactive molecule, which has been modified by genetic engineering, to restore blood flow. Identify the bioactive molecule and its source organism.

Step-by-step solution

Patients who have undergone myocardial infarction (heart attack) require a 'clot buster' to remove clots from their blood vessels and restore blood flow. Streptokinase is the bioactive molecule used clinically as a clot buster. It is produced by the bacterium Streptococcus and modified by genetic engineering. Statins are blood-cholesterol lowering agents produced by the yeast Monascus purpureus. Cyclosporin A is an immunosuppressive agent produced by the fungus Trichoderma polysporum. Staphylococcus is a different